Shasun Ties with Merck & Co.

Shasun Chemicals & Drugs (Chennai, India), a pharmaceutical company, says it has entered into an active pharma ingredient (API) technology licensing agreement with Merck & Co. Inc. (Whitehouse Station, NJ). Under the non-exclusive agreement, Shasun will provide Merck with the use of its proprietary cross-coupling copper technology (known as Buchwald technology) to manufacture and commercialize APIs.  “This is an important milestone for Shasun in making this technology widely accessible and paving the way for further collaborations,” says...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers